Gene for increasing plant weight and method for using the same

ABSTRACT

A gene having novel functions is searched for, by which plant weight (that is, biomass level) can be increased and by which substance productivity can be increased or decreased. A chimeric protein is expressed in which a transcriptional factor comprising the amino acid sequence shown in SEQ ID NO: 2, 4, or 6 is fused to a functional peptide that converts an arbitrary transcriptional factor into a transcriptional repression factor.

TECHNICAL FIELD

The present invention relates to a gene for increasing plant weight anda method for using the same.

BACKGROUND ART

The term “biomass” generally refers to the total amount of organismsthat inhabit or organic matter that exists in a given area. Particularlyregarding plants, plant biomass refers to the dry weight of the plantsthat exists in a given area. The unit of such biomass is quantifiedusing mass or energy level. The expression “biomass is a synonym of aterm “an amount of an organism.” In the case of plant biomass, the term“standing crop” is also used. Plant biomass is generated by fixingcarbon dioxide in the air using solar energy, so that it can be capturedas so-called carbon neutral energy. Therefore, an increase in such plantbiomass has effects of terrestrial environmental protection, preventionof global warming, and reduction of greenhouse gas emissions. Hence,technologies for increasing plant biomass have high industrialimportance.

In addition, plants are cultivated for their partial tissues (e.g.,seeds, roots, and leaf stems) or for production of various substancessuch as fats and oils. For example, as fats and oils produced by plants,soybean oil, sesame oil, olive oil, coconut oil, rice oil, cottonseedoil, sunflower oil, corn oil, safflower oil, palm oil, rapeseed oil, andthe like are conventionally known and broadly used for household orindustrial applications. Also, fats and oils produced by plants are usedas raw materials for biodiesel fuel or bioplastics, allowing theapplicability thereof to spread as alternatives to petroleum as energysources.

Under such circumstances, improvement of productivity per unit ofcultivated area is required for industrially successful fat and oilproduction using plants. Assuming that the number of cultivated plantsper unit of cultivated area remains constant, it is understood thatimprovement in fat and oil production per individual plant is needed.When fats and oils are collected from seeds harvested from plant bodies,it is expected that improved fat and oil production per individual plantcan be achieved by a technology for improving the seed yield perindividual plant, a technology for improving the fat and oil contents inseeds, or the like.

Technologies for increasing the fat and oil production from plant seedsare mainly divided into those based on improved cultivation techniquesand those based on development of cultivars for increased fat and oilproduction. Methods for developing cultivars with increased fat and oilproduction are mainly divided into conventional breeding techniquesmainly composed of mating technologies and molecular breeding methodsusing genetic recombination. As technologies for increased fat and oilproduction using genetic recombination, A) a technology that involvesaltering the synthesis system for seed triacylglycerol (TAG), which is amajor ingredient of plant fats and oils, and B) a technology thatinvolves altering various control genes for controlling plantmorphological formation, metabolism, and the expression of genesinvolved therein are known.

Possible examples of method A) above include methods for increasing theamount of TAG synthesized using sugar produced by photosynthesis as araw material. These include (1) a method that involves enhancingactivity for the synthesis of fatty acid or glycerol, which is acomponent of TAG from sugar; and (2) a method for enhancing the reactionby which TAG is synthesized from glycerol and fatty acid. Concerningsuch methods, the following technologies have been reported astechnologies using genetic engineering techniques. An example of (1) isprovided in a report (Plant Physiology (1997) Vol. 11, pp. 75-81)wherein it was noted that seed fat and oil contents were improved by 5%via overexpression of cytoplasmic acetyl-coenzyme A carboxylase (ACCase)of Arabidopsis thaliana in rapeseed plastids. Also, an example of (2) isprovided in a report (Plant Physiology (2001), Vol. 126, pp. 861-874)concerning a technology for increased fat and oil production viaoverexpression of DGAT (diacylglycerol acyltransferase), which undergoesacyl transfer to the sn-3 position of diacylglycerol. In the reportregarding this method, fat and oil contents and seed weights wereincreased as the DGAT expression levels were increased, so that thenumber of seeds per individual plant could increase. Arabidopsisthaliana seed fat and oil content was increased by 46% with the use ofthis method, and the fat and oil content per individual plant wasincreased by approximately 125% at maximum.

In addition, a possible example of method B) above is a method thatinvolves controlling the expression of a transcriptional factor geneinvolved in control of the expression of a biosynthesis system enzymegene. An example thereof is given in WO01/36597. In WO01/36597, atechnique was employed that involves producing recombinant plantsthrough exhaustive overexpression or knock-out of a transcriptionalfactor and then selecting a gene that enhances seed fat and oilcontents. WO01/36597 states that seed fat and oil contents wereincreased by 23% through overexpression of the ERF subfamily B-4transcriptional factor gene. However, WO01/36597 does not stateincreases or decreases in the fat and oil content per individual plant.Plant J. (2004) 40, 575-585 describes that seed fat and oil contents canbe improved by overexpression of WRINKLED1, the transcriptional factorcontaining the AP2/EREB domain.

Furthermore, when a hydrocarbon component such as cellulose contained inplant bodies is glycosylated and then alcohol is produced byfermentation, fat and oil components contained in plants becomeimpurities that can cause reduced glycosylation efficiency in aglycosylation step. Therefore, if fat and oil contents can be decreased,glycosylation efficiency in a glycosylation step can be improved andthus improved alcohol productivity can be expected. For example, PlantJ. (2004) 40, 575-585 discloses that in the case of the WRI1/ASML1 (AP2family transcriptional factor; AGI-code: AT3g54320)-deficient line,seeds were wrinkled and the fat and oil contents were decreased.Furthermore, WO01/35727 discloses the following: the seed fat and oilcontent was decreased by 13% through overexpression of AT3g23250(MYB15); the seed fat and oil content was decreased by 12% throughoverexpression of AT1g04550 (IAA12); and the seed fat and oil contentwas decreased by 16% through overexpression of AT1g66390 (MYB90).

Moreover, several attempts to improve biomass have been carried out. Forexample, Proc. Natl. Acad. Sci. U.S.A., 2000, Jan. 18: 97(2), 942-947discloses that plant organ cell number, organ size, and individual plantsize were increased through overexpression of the At4g37750(AINTEGUMENTA) gene. Similarly, Plant Cell, 2003, September; 15(9),1951-1961 discloses that when overexpression of At2g44080 (ARL) wascaused, plant organ cell number, organ size, and individual plant sizewere increased. Also, Plant J. (2006) July, 47(1), 1-9 discloses thatcell division was activated through overexpression of At1g105690 (AVP1),so that individual plant size was increased. Furthermore, Development2006, January; 133 (2), 251-261 reports that when At5g62000 (ARF2) wasdeficient, seeds and flower organs became larger in size.

However, although the above molecular breeding methods for improvementof various characters have been developed, no technology has reached apractical level that would allow both increased biomass and improved ordecreased fat and oil productivity.

This may be because truly excellent genes remain undiscovered andbecause novel recombinant cultivars effective at test stages are unableto exert effects as desired at practical stages under various naturalenvironments. Furthermore, regarding quantitative character such asincreased plant weight and productivity of a target substance, manygenes are involved in various steps, ranging from control systems tometabolic systems. Hence, it has been difficult to discover and developa truly excellent useful gene for improvement of quantitativecharacters. Objects required to address these problems are: discovery ofa novel gene with drastically high effects; and development of a genecapable of exerting effects under practical environmental conditions,even if its effect levels are equivalent to those of conventional genes.Furthermore, it is expected that practical levels would be achieved bythe simultaneous use of a plural number of genes, even if each of thegenes has effect level equivalent to or lower than those of conventionalgenes. Accordingly, another object is to develop a plurality of geneshaving different functions.

DISCLOSURE OF THE INVENTION Object to Be Achieved By the Invention

In view of the above-described circumstances, an object of the inventionis to search for a gene having novel functions by which plant weight(that is, plant biomass level) can be increased and by means of whichsubstance productivity can be increased or decreased, so as to provide atechnology capable of improving the properties of plant bodies.

Means to Achieve the Object

As a result of intensive studies to achieve the above objects, thepresent inventors have discovered, that various quantitative characterscan be improved, through expression of a chimeric protein in which aspecific transcriptional factor is fused to a functional peptide(hereinafter, this may also be referred to as a repressor domain) thatconverts an arbitrary transcriptional factor to a transcriptionalrepression factor. Particularly, the present inventors have discoveredthat plant weight (that is, plant biomass level) can be increased andthat substance productivity can be increased or decreased. Thus, thepresent inventors have completed the present invention.

The plant body according to the present invention expresses a chimericprotein wherein a transcriptional factor comprising any one of thefollowing proteins (a) to (c) is fused to a functional peptide thatconverts an arbitrary transcriptional factor to a transcriptionalrepression factor:

(a) a protein comprising the amino acid sequence shown in SEQ ID NO: 2,4, or 6;

(b) a protein comprising an amino acid sequence that has a deletion, asubstitution, an addition, or an insertion of one or a plurality ofamino acids with respect to the amino acid sequence shown in SEQ ID NO:2, 4 or 6 and having activity of accelerating transcription; and

(c) a protein encoded by a polynucleotide hybridizing under stringentconditions to a polynucleotide that comprises a nucleotide sequencecomplementary to the nucleotide sequence shown in SEQ ID NO: 1. 3, or 5and having activity of accelerating transcription.

In the plant body according to the present invention, thetranscriptional control activity and particularly the activity ofaccelerating transcription of a predetermined transcriptional factor ispreferably suppressed by fusion of a functional peptide. Examples of theabove functional peptide include the peptides represented by thefollowing formulae (1) to (8), respectively:

X1-Leu-Asp-Leu-X2-Leu-X3   (1)

(wherein X1 denotes 0 to 10 amino acid residues, X2 denotes Asn or Glu,and X3 denotes at least 6 amino acid residues.)

Y1-Phe-Asp-Leu-Asn-Y2-Y3   (2)

(wherein Y1 denotes 0 to 10 amino acid residues. Y2 denotes Phe or He,and Y3 denotes at least 6 amino acid residues.)

Z1-Asp-Leu-Z2-Leu-Arg-Leu-Z3   (3)

(wherein Z1 denotes Leu, Asp-Leu, or Leu-Asp-Leu, Z2 denotes Glu, Gln,or Asp, and Z3 denotes 0 to 10 amino acid residues.)

Asp-Leu-Z4-Leu-Arg-Leu   (4)

(wherein Z4 denotes Glu, Gln, or Asp.)

alpha1-Leu-beta1-Leu-gamma1-Leu   (5)

alpha1-Leu-beta1-Leu-gamma2-Leu   (6)

alpha1-Leu-beta2-Leu-Arg-Leu   (7)

alpha2-Leu-beta1-Leu-Arg-Leu   (8)

(and in the formulae (5) to (8), alpha1 denotes Asp, Asn, Glu, Gln, Thr,or Ser, alpha2 denotes Asn, Glu, Gln, Thr, or Ser, beta1 denotes Asp,Gln, Asn, Arg, Glu, Thr, Ser, or His, beta2 denotes Asn, Arg, Thr, Ser,or His, gamma1 denotes Arg, Gln, Asn, Thr, Ser, His, Lys, or Asp, andgamma2 denotes Gln, Asn, Thr, Ser, His, Lys, or Asp.) The plant weightof the plant body according to the present invention is significantlyimproved. Here, the term “significantly” refers to a situation in whichthe plant weight is increased to a statistically significant extentcompared with the plant weight of a plant body not expressing the abovechimeric protein.

Also, in the plant body according to the present invention, substanceproductivity per individual plant, and particularly, the productivity offats and oils contained in seeds, is significantly improved ordecreased. Examples of specific tissues include seeds. Here, the term“significantly” refers to a situation in which substance productivity isincreased or decreased to a statistically significant extent comparedwith substance productivity in a plant body not expressing the abovechimeric protein.

Meanwhile, according to the present invention, the above-describedchimeric protein, a gene encoding the chimeric protein, an expressionvector containing the gene, and a transformant containing the gene canbe provided.

Effect of the Invention

The plant body according to the present invention has improved plantweight; that is, it exhibits an improved biomass level. Therefore, bythe use of the plant body according to the present invention,improvement can be achieved in terms of productivity of a substance thatis produced using a plant body itself or a part of a plant body as a rawmaterial, such as bioalcohol. Thus, a substance of interest can beproduced at low cost according to the present invention.

BEST MODE OF CARRYING OUT THE INVENTION

The present invention will be described in detail as follows.

The plant body according to the present invention expresses a chimericprotein in which a predetermined transcriptional factor is fused to afunctional peptide that converts an arbitrary transcriptional factor toa transcriptional repression factor and has a significantly improvedplant weight (that is, a plant biomass level) compared with that ofwild-type plant bodies. Specifically, the plant body according to thepresent invention is produced by causing a desired (target) plant toexpress a transcriptional factor in the form of a chimeric protein withthe above functional peptide, so as to significantly improve the plantbiomass level of the plant. Also, the plant body of the presentinvention has significantly improved or decreased substance productivityper individual plant and particularly improved productivity of fats andoils contained in seeds, compared with wild-type plant bodies.

In particular, it is preferable that, in the plant body according to thepresent invention, the activity of accelerating transcription of thetranscriptional factor is suppressed through fusion of the factor withthe above functional peptide. That is, preferably, the plant bodyaccording to the present invention is characterized in that, as a resultof expression of a chimeric protein in which the above functionalpeptide is fused to a transcriptional factor, the transcriptionalrepression effect resulting from the above functional peptide appears asa dominant character.

Here, the expression, “improvement of the plant weight” is synonymouswith namely, “increased biomass,” that is; increased biomass per givenarea. Two technologies contribute to increase the biomass per givenarea: a technology for increasing the degree of dense planting (thenumber of plants per given area) and a technology for increasing theweight or energy level per individual plant. Hence, not only the dryweight per given area, but also the dry weight per individual plant canalso be evaluated as plant biomass.

Accordingly, the biomass as defined in the present invention may be dryplant weight per individual plant, the dry weight (per individual plant)of the above ground part of a plant, or the weight of a specific tissue.Here, the term “tissue weight per individual plant” refers to the weightof at least one or more types of tissue selected from among seeds,roots, leaves, stems, flowers, pollens, and the like, composing a plant.

The term “substance productivity per individual plant” refers to thecontent per unit volume of one of various substances generated byplants. A substance to be used herein is not particularly limited andmay be a substance that is originally generated by a plant body or asubstance that is not originally generated by a plant body but can begenerated by the plant body as a result of genetic engineering, or thelike.

Particularly, if the content of a product of interest per tissue isincreased, the present invention is industrially useful, sincepurification cost and transportation cost can be reduced. Particularly,a product of interest may be lignocellulose the weight of which accountsfor most weight of the plant or plant oil that is industrially used asseed oil. Plant oil may be simple lipid that is an ester of fatty acidand alcohol, complex lipid containing phosphorus, sugar, nitrogen, andthe like, or fatty acid itself. Alcohol of simple lipid may behigh-molecular-weight higher alcohol or polyalcohol such as glycerol(glycerine). Fatty acid of simple lipid may be saturated fatty acid orunsaturated fatty acid, as well as, special fatty acid containing ahydroxyl group and an epoxy group. Simple lipid that is an ester ofglycerol and fatty acid may be monoacylglycerol, diacylglycerol, ortriacylglycerol.

Meanwhile, depending on the application of a plant body, a predeterminedsubstance contained in the plant body may be an impurity. Therefore, thelower the productivity of a predetermined substance, the more decreasedimpurity content, leading to high industrial usefulness. For example,when lignocellulose contained in a plant body is glycosylated, a fat andoil component contained in the plant body as an impurity may adverselyaffect glycosylation efficiency. Hence, if the productivity of fats andoils is decreased, the efficiency of a glycosylation step of theproduction process for bioalcohol or the like using plant bodies can beimproved.

The following explanation is given by exemplifying fats and oils assubstances that improve or decrease productivity, but the technicalscope of the present invention is not limited thereto. The presentinvention is similarly applicable to substances to be generated byplants other than fats and oils.

The plant body to be used herein is not particularly limited. Any plantcan be a target. Particularly preferably such target plants are thoseconventionally used for production of fats and oils. Examples of suchtarget plants include soybean, sesame, olive oil, coconut, rice, cotton,sunflower, corn, sugarcane, jatropha, palm coconut, tobacco, safflower,and rapeseed. Also, another possible target plant is Arabidopsisthaliana that has been broadly used as a model organism for plant geneanalysis, for which a method for gene expression analysis has beenestablished.

Also, the transcriptional repression is the activity of a chimericprotein comprising a transcriptional factor, by which a cis sequence tobe recognized by the transcriptional factor or a cis sequence analogousthereto in another transcriptional factor is recognized, so as toaggressively suppress downstream gene expression. Transcriptionalrepression can also be referred to as a transcriptional repressionfactor. A technique for undergoing transcriptional repression possessedas activity by a chimeric protein comprising, a transcriptional factoris not particularly limited. Particularly, a method for constructing achimeric protein (fusion protein) to which a repressor domain sequenceor an SRDX sequence has been added is most preferable.

A repressor domain sequence in this technique is an amino acid sequencecomposing a peptide that converts an arbitrary transcriptional factor toa transcriptional repression factor and the present inventors havediscovered various types thereof. Regarding methods using repressordomain sequences, JP Patent Publication (Kokai) No. 2001-269177 A, JPPatent Publication (Kokai) No. 2001-269178 A, JP Patent Publication(Kokai) No. 2001-292776 A, JP Patent Publication (Kokai) No. 2001-292777A, JP Patent Publication (Kokai) No. 2001-269176 A, JP PatentPublication (Kokai) No. 2001-269179 A, International Patent PublicationWO03/055903, Pamphlet, Ohta, M., Matsui, K., Hiratsu, K., Shinshi, H.and Ohme-Takagi, M., The Plant Cell, Vol. 13, 1959-1968, August, 2001,and Hiratsu, K., Ohta, M., Matsui, K., Ohme-Takagi, M., FEBS Letters 514(2002) 351-354 can he referred to, for example. A repressor domainsequence is excised from Class II ERF (Ethylene Responsive ElementBinding Factor) protein or a plant zinc finger protein (e.g.,Arabidopsis thaliana SUPERMAN protein) and has an extremely simplestructure.

Examples of a transcriptional factor that is expressed in the form of achimeric protein include a transcriptional factor (hereinafter, simplyreferred as the “transcriptional factor At3g04070.” The same applies tothe following examples) specified under AGI code At3g04070 ofArabidopsis thaliana, the transcriptional factor At1g18330, and thetranscriptional factor At3g45150. In addition, the transcriptionalfactor At3g04070 is a transcriptional factor belonging to the NACfamily. The transcriptional factor At1g18330 is a transcriptional factorbelonging to the single MYB (R3-MYB) family. The transcriptional factorAt3g45150 is a transcriptional factor belonging to the TCP family. Theamino acid sequence of the transcriptional factor At3g04070 is shown inSEQ ID NO: 2 and the nucleotide sequence of a gene encoding thetranscriptional factor At3g04070 is shown in SEQ ID NO: 1. The aminoacid sequence of the transcriptional factor At1g18330 is shown in SEQ IDNO: 4 and the nucleotide sequence of a gene encoding the transcriptionalfactor At1g18330 is shown in SEQ ID NO: 3. The amino acid sequence ofthe transcriptional factor At3g45150 is shown in SEQ ID NO: 6 and thenucleotide sequence of a gene encoding the transcriptional factorAt3g45150 is shown in SEQ ID NO: 5.

Moreover, the transcriptional factor At3g04070, the transcriptionalfactor At1g18330, and the transcriptional factor At3g45150 that aretargets of a chimeric protein are not limited to those comprising aminoacid sequences shown in SEQ ID NOS: 2, 4, and 6, respectively. Such atarget transcriptional factor may comprise an amino acid sequence thathas a deletion, a substitution, an addition, or an insertion of one or aplurality of amino acids with respect to the amino acid sequence shownin SEQ ID NO: 2, 4, or 6 and having activity of acceleratingtranscription. Here the term “a plurality of amino acids” refers to 1 to20, preferably 1 to 10, more preferably 1 to 7, further more preferably1 to 5, and particularly preferably 1 to 3 amino acids, for example. Inaddition, a deletion, a substitution, or an addition of amino acids canbe performed by altering a nucleotide sequence encoding the abovetranscriptional factor by techniques known in the art. A mutation can beintroduced into a nucleotide sequence by a known technique such as theKunkel method or the Gapped duplex method or a method according thereto.For example, a mutation is introduced using a mutagenesis kit usingsite-directed mutagenesis (e.g., Mutant-K and Mutant-G (both of whichare trade names, manufactured by TAKARA Bio)) or using a LA PCR in vitroMutagenesis series kit (trade name, manufactured by TAKARA Bio). Also, amutagenesis method may be a method that uses a chemical agent formutation represented by EMS (ethylmethane sulfonate), 5-bromouracil,2-aminopurine, hydroxylamine, N-methyl-N′-nitro-N-nitrosoguanidine, orother carcinogenic compounds or a method based on radiation treatmenttypically using an X ray, an alpha ray, a beta ray, a gamma-ray, or anion beam or ultraviolet {UV} treatment.

Furthermore, examples of a transcriptional factor that is a target of achimeric protein are not limited to the transcriptional factorAt3g04070, the transcriptional factor At1g18330, and the transcriptionalfactor At3g45150 of Arabidopsis thaliana. Examples thereof also includetranscriptional factors (hereinafter, referred as homologoustranscriptional factors) having the same functions in plants (e.g., theabove-mentioned plants) other than Arabidopsis thaliana. Transcriptionalfactors homologous to the transcriptional factor At3g04070, thetranscriptional factor At1g18330, and the transcriptional factorAt3g45150 can be searched for from plant genome information to besearched based on the amino acid sequence of the transcriptional factorAt3g04070, the transcriptional factor At1g18330, or the transcriptionalfactor At3g45150 or the nucleotide sequence of each gene thereof, aslong as the plant genome information has been revealed. At this time, ahomologous transcriptional factor is searched for as an amino acidsequence having 70% or more, preferably 80% or more, more preferably 90%or more, and most preferably 95% or more homology with respect to theamino acid sequence of the transcriptional factor At3g04070, thetranscriptional factor At1g18330, or the transcriptional factorAt3g45150. Here, the value of homology refers to a value found usingdatabase that store a computer program mounting blast algorithm, genesequence information, and default setting.

Moreover, when plant genome information is unknown, a homologous genecan be identified by extracting a genome from a target plant orconstructing a cDNA library of a target plant, and then isolating agenomic region or cDNA hybridizing under astringent conditions to atleast a part of a gene encoding the transcriptional factor At3g04070,the transcriptional factor At1g18330, or the transcriptional factorAt3g45150. Here, the term “stringent conditions” refers to conditionswhere a so-called specific hybrid is formed, but no non-specific hybridis formed. For example, hybridization is performed at 45 degrees C.using 6×SSC (sodium chloride/sodium citrate) and then washing isperformed under conditions of 50 degrees C.-65 degrees C., 0.2-1×SSC,and 0.1% SDS. Alternatively, examples thereof include hybridization at65 degrees C.-70 degrees C. using 1×SSC followed by washing at 65degrees C.-70 degrees C. using 0.3×SSC. Hybridization can be performedby a conventionally known method such as a method described in J.Sambrook et al. Molecular Cloning, A Laboratory Manual, 2nd Ed., ColdSpring Harbor Laboratory (1989).

The plant body according to the present invention is characterized inthat as a result of expression of the above-described chimeric proteinof a transcriptional factor and a functional peptide, the plant weight(that is, a biomass level) is significantly improved, and that fat andoil production is significantly changed (improved or decreased).Particularly, the plant body according to the present invention ischaracterized in that, through preparation of such a chimeric protein, atarget transcriptional factor is expressed in the form of the chimericprotein with suppressed activity of accelerating transcription, andtranscriptional repression activity is expressed to recognize a cissequence having homology with a cis sequence that is recognized by thetarget transcriptional factor. Furthermore, the plant body is alsocharacterized in that the plant weight (that is, biomass level) issignificantly improved, and that fat and oil production is significantlychanged (improved or decreased) by varying the affinity specificity ofthe target transcriptional factor for another factor, nucleic acid,lipid, or carbohydrate. At this time, in the above plant body, achimeric protein may be prepared via alteration of an endogenoustranscriptional factor or a gene encoding a chimeric protein may beintroduced and then the gene is expressed.

As an example, a preferable technique involves introducing a geneencoding chimeric protein (fusion protein) in which the above-describedtranscriptional factor is fused to a functional peptide that converts anarbitrary transcriptional factor to a transcriptional repression factorinto a target plant and then causing expression of the chimeric protein(fusion protein) within the plant.

The term “transcriptional factor with suppressed activity ofaccelerating transcription” described in this Description is notparticularly limited and refers to a transcriptional factor havingsignificantly decreased activity of accelerating transcription that isoriginally possessed by the transcriptional factor. Also, the term“functional peptide that converts an arbitrary transcriptional factor toa transcriptional repression factor” refers to, when it is fused to anarbitrary transcriptional factor to form a chimeric protein, a peptidethat has functions so that the resulting transcriptional factor hassignificantly decreased activity of accelerating transcription that isoriginally possessed by the transcriptional factor (it may also bereferred to as a transcriptional repression conversion peptide). Such “afunctional peptide that converts an arbitrary transcriptional factor toa transcriptional repression factor” is not particularly limited, but ispreferably a peptide comprising an amino acid sequence known asparticularly a repressor domain sequence or an SRDX sequence. Suchtranscriptional repression conversion peptide is described in detail inJP Patent Publication (Kokai) No. 2005-204657 A and all peptidesdisclosed in this publication can be used herein.

Examples of the transcriptional repression conversion peptide includethe peptides of the amino acid sequences represented by the followingformulae (1) to (8), respectively.

X1-Leu-Asp-Leu-X2-Leu-X3   (1)

(wherein X1 denotes 0 to 10 amino acid residues, X2 denotes Asn or Glu,and X3 denotes at least 6 amino acid residues)

Y1-Phe-Asp-Leu-Asn- Y2-Y3   (2)

(wherein Y1 denotes 0 to 10 amino acid residues, Y2 denotes Phe or Ile,and Y3 denotes at least 6 amino acid residues)

Z1-Asp-Leu-Z2-Leu-Arg-Leu-Z3   (3)

(wherein Z1 denotes Leu, Asp-Leu, or Leu-Asp-Leu, Z2 denotes Glu, Gln,or Asp, and Z3 denotes 0 to 10 amino acid residues)

Asp-Leu-Z4-Leu-Arg-Leu   (4)

(wherein Z4 denotes Glu, Gln, or Asp)

alpha1-Leu-beta1-Leu-gamma1-Leu   (5)

alpha1-Leu-beta1-Leu-gamma2-Leu   (6)

alpha1-Leu-beta2-Leu-Arg-Leu   (7)

alpha2-Leu-beta1-Leu-Arg-Leu   (8)

(and in the formulae (5) to (8), alpha1 denotes Asp, Asn, Glu, Gln, Thr,or Ser, alpha2 denotes Asn, Glu, Gln, Thr, or Ser, beta1 denotes Asp,Gln, Asn, Arg, Glu, Thr, Ser, or His, beta2 denotes Asn, Arg, Thr, Ser,or His, gamma1 denotes Arg, Gln, Asn, Thr, Ser, His, Lys, or Asp, andgamma2 denotes Gln, Asn, Thr, Ser, His, Lys, or Asp)

Transcriptional Repression Conversion Peptide of Formula (1)

In the transcriptional repression conversion peptide of the aboveformula (1), the number of amino acid residues denoted by X1 above mayrange from 0 to 10. Also, the specific types of amino acid composing theamino acid residues denoted by X1 are not particularly limited, and theymay be of any type. The amino acid residues denoted by X1 are preferablyas short as possible, in view of ease of synthesis of thetranscriptional repression conversion peptide of formula (1). The numberof amino acid residues that are specifically denoted by X1 is preferably5 or less.

Similarly, in the case of the transcriptional repression conversionpeptide of formula (1), the number of amino acid residues denoted by X3above may be at least 6. Also, the specific types of amino acidcomposing amino acid residues denoted by X3 are not particularlylimited, and they may be of any type.

Transcriptional Repression Conversion Peptide of Formula (2)

In the transcriptional repression conversion peptide of formula (2)above, similarly to the case of X1 of the transcriptional repressionconversion peptide of formula (1) above, the number of amino acidresidues denoted by Y1 above may range from 0 to 10. Also, the specifictypes of amino acid composing the amino acid residues denoted by Y1 arenot particularly limited, and they may be of any type. The specificnumber of amino acid residues denoted by Y1 is preferably 5 or less.

In the transcriptional repression conversion peptide of formula (2)above, similarly to the case of X3 of the transcriptional repressionconversion peptide of formula (1) above, the number of amino acidresidues denoted by Y3 above may be at least 6. Also, the specific typesof amino acid composing the amino acid residues denoted by Y3 are notparticularly limited, and they may be of any type.

Transcriptional Repression Conversion Peptide of Formula (3)

In the transcriptional repression conversion peptide of formula (3)above, the amino acid residues denoted by Z1 above includes 1 to 3 Leuresidues. When the number of amino acids is 1, the amino acid is Leu.When the number of amino acids is 2, they are Asp-Leu. When the numberof amino acids is 3, they are Leu-Asp-Leu.

Meanwhile, in the transcriptional repression conversion peptide offormula (3) above, the number of amino acid residues denoted by Z3 abovemay range from 0 to 10. Also, the specific types of amino acid composingamino acid residues denoted by Z3 are not particularly limited, and theymay be of any type. Specifically, the number of amino acid residuesdenoted by Z3 is more preferably 5 or less. Specific examples of aminoacid residues denoted by Z3 include, but are not limited to, Gly,Gly-Phe-Phe, Gly-Phe-Ala, Gly-Tyr-Tyr, and Ala-Ala-Ala.

Moreover, the total number of amino acid residues in the transcriptionalrepression conversion peptide represented by formula (3) is notparticularly limited. In view of the ease upon synthesis, the numberthereof is preferably 20 amino acids or less.

Transcriptional Repression Conversion Peptide of Formula (4)

The transcriptional repression conversion peptide of formula (4) is ahexamer (6mer) consisting of 6 amino acid residues. In addition, whenthe amino acid residue denoted by Z4 in the transcriptional repressionconversion peptide of formula (4) above is Glu, the amino acid sequencecorresponds to a sequence ranging from amino acid 196 to amino acid 201of Arabidopsis thaliana SUPERMAN protein (SUP protein).

Various transcriptional repression conversion peptides explained abovecan alter the properties of the above described transcriptional factorby fusion thereof to the transcriptional factor, so as to form achimeric protein (fusion protein). Specifically, through fusion to theabove described transcriptional factor so as to form a chimeric protein(fusion protein), such peptide can alter the relevant transcriptionalfactor to a transcriptional repression factor or a negativetranscription coupling factor. Furthermore, such peptide can alsoconvert a transcriptional repression factor that is not dominant to adominant transcriptional repression factor.

A chimeric protein (fusion protein) can also be produced by obtaining afusion gene using a polynucleotide encoding the above transcriptionalrepression conversion peptide and a gene encoding a transcriptionalfactor. Specifically, a fusion gene is constructed by linking apolynucleotide (referred to as transcriptional repression conversionpolynucleotide) encoding the above transcriptional repression conversionpeptide and a gene encoding the above transcriptional factor and thenintroduced into plant cells, so that a chimeric protein (fusion protein)can be produced by the cells. A specific example of the nucleotidesequence of the above transcriptional repression conversionpolynucleotide is not particularly limited, as long as it is based ongenetic codes and contains a nucleotide sequence corresponding to theamino acid sequence of the above transcriptional repression conversionpeptide. Also, if necessary, the above transcriptional repressionconversion polynucleotide may further contain a nucleotide sequence thatserves as a joining site for linking with a transcriptional factor gene.Furthermore, when the amino acid reading frame of the abovetranscriptional repression conversion polynucleotide does not agree withthe reading frame of a transcriptional factor gene, such polynucleotidemay contain an additional nucleotide sequence for their agreement.Furthermore, such polynucleotide may also contain various additionalpolypeptides such as a polypeptide having a linker function for linkinga transcriptional factor and a transcriptional repression conversionpeptide and polypeptides (e.g., His, Myc, or Flag) for epitope labelingof the chimeric protein (fusion protein). Furthermore, the abovechimeric protein (fusion protein) may contain structures other thanpolypeptides, if necessary, such as a sugar chain and an isoprenoidgroup.

A method for producing plant bodies is not particularly limited, as longas it comprises a process for production of the above-described chimericprotein of a transcriptional factor and a transcriptional repressionconversion peptide in plant bodies. An example thereof is a productionmethod comprising the steps of constructing an expression vector,transformation, selection, and the like. Each step is specificallyexplained as follows.

Steps of Constructing Expression Vector

The step of constructing an expression vector is not particularlylimited, as long as it is a step of constructing a recombinantexpression vector containing a gene encoding the above transcriptionalfactor, a transcriptional repression conversion polynucleotide, and apromoter. As a vector to be used as a template for a recombinantexpression vector, various conventionally known vectors can be used. Forexample, plasmids, phages, or cosmids can be used. A vector can beappropriately selected therefrom depending on a plant cell into whichthe vector is introduced or a method employed for introduction. Specificexamples thereof include pBR322, pBR325, pUC19, pUC119, pBluescript,pBluescriptSK, and pBI vectors. Particularly, when a method forintroducing a vector into a plant body is a method using Agrobacterium,a pBI binary vector is preferably used. Specific examples of such pBIbinary vector include pBIG, pBIN19, pBI101, pBI121, and pBIb 221.

A promoter to be used herein is not particularly limited, as long as itenables gene expression within a plant body. A known promoter can bepreferably used. Examples of such promoter include a cauliflower mosaicvirus 35S promoter (CaMV35S), various actin gene promoters, variousubiquitin gene promoters, a promoter of a nopaline synthase gene, atobacco PR1a gene promoter, a tomato ribulose 1,5-bisphosphatecarboxylase oxidase small subunit gene promoter, a napin gene promoter,and an oleosin gene promoter. Of these promoters, a cauliflower mosaicvirus 35S promoter, actin gene promoters, or ubiquitin gene promoterscan he more preferably used. The use of each of the above promotersenables strong expression of an arbitrary gene after its introductioninto plant cells. A promoter is ligated to and introduced into a vector,so that a fusion gene can be expressed in which a gene encoding atranscriptional factor or a transcription coupling factor is linked to atranscriptional repression conversion polynucleotide. The specificstructure of a recombinant expression vector is not particularlylimited.

In addition, a recombinant expression vector nay further contain otherDNA segments in addition to a promoter and the above fusion gene.Examples of such other DNA segments are not particularly limited andinclude a terminator, a selection marker, an enhancer, and a nucleotidesequence for enhancing translation efficiency. Also, the aboverecombinant expression vector may further has a T-DNA region. A T-DNAregion can enhance gene transfer efficiency particularly when the aboverecombinant expression vector is introduced into plant bodies usingAgrobacterium.

A transcriptional terminator to be used herein is not particularlylimited, as long as it has functions as a transcription termination siteand may be a known transcriptional terminator. For example,specifically, a transcription termination region (Nos terminator) of anopaline synthase gene, a transcription termination region (CaMV35Sterminator) of cauliflower mosaic virus 35S, and the like can bepreferably used. Of these examples, the Nos terminator can be morepreferably used. In the above recombinant vector, a transcriptionalterminator is placed at an appropriate position, so as to be able toprevent the occurrence of phenomena such as the synthesis ofunnecessarily long transcripts and reduced number of copies of a plasmidbecause of a strong promoter, after introduction into plant cells.

As a transformant selection marker, a drug resistance gene can be used,for example. A specific example of such drug resistance gene is a drugresistance gene against hygromycin, bleomycin, kanamycin, gentamicin,chloramphenicol, or the like. Hence, transformed plant bodies can beeasily selected through selection of plant bodies that can grow inmedium containing the above antibiotic.

An example of a nucleotide sequence for enhancing translation efficiencyis a tobacco mosaic virus-derived omega sequence. The omega sequence isplaced in the untranslated region (5′ UTR) of a promoter, allowing thetranslation efficiency of the above fusion gene to be enhanced. Asdescribed above, the above recombinant expression vector can containvarious DNA segments depending on purpose.

A method for constructing a recombinant expression vector is notparticularly limited. The above promoter, a gene encoding atranscriptional factor, and a transcriptional repression conversionpolynucleotide, as well as (if necessary) the above other DNA segmentsare introduced in a predetermined order into a vector appropriatelyselected as a template. For example, a fusion gene is constructed bylinking a gene encoding a transcriptional factor and a transcriptionalrepression conversion polynucleotide. Next the fusion gene and apromoter (and if necessary, a transcriptional terminator and the like)are linked to construct an expression cassette and then the expressioncassette is introduced into a vector.

Upon construction of a chimeric gene (fusion gene) and that of anexpression cassette, for example, cleavage sites of DNA segments aretreated to have protruding ends complementary from each other. Reactionis performed using a ligation enzyme, making it possible to determinethe order of the DNA segments. In addition, when an expression cassettecontains a terminator, from upstream, a promoter, the above chimericgene, and a terminator should be placed in this order. Also, reagentsfor construction of a recombinant expression vector; that is, the typesof restriction enzyme and ligation enzyme, for example, are also notparticularly limited. Commercially available reagents may heappropriately selected and then used.

Moreover, a method for proliferating the above recombinant expressionvector (production method) is also not particularly limited.Conventionally known methods can be used herein. In general, such vectormay be proliferated within Escherichia coli as a host. At this time, apreferred type of Escherichia coli may be selected depending on the typeof a vector.

Transformation Step

A transformation step that is performed in the present invention is astep of introducing the above fusion gene into plant cells using theabove recombinant expression vector, so that the fusion gene isexpressed. A method for introducing such gene into plant cells using arecombinant expression vector (transformation method) is notparticularly limited. Any appropriate conventionally known method can beemployed depending on plant cells. Specifically, for example, a methodthat uses Agrobacterium or a method that involves directly introducingsuch gene into plant cells can be employed herein. As such method thatuses Agrobacterium, for example, a method described in Bechtold, E.,Ellis, J. and Pelletier, G. (1993) In Planta Agrobacterium-mediated genetransfer by infiltration of adult Arabidopsis plants. C. R. Acad. Sci.Paris Sci. Vie, 316, 1194-1199. or a method described in Zyprian E, KadoCl, Agrobacterium-mediated plant transformation by novel mini-T vectorsin conjunction with a high-copy vir region helper plasmid. PlantMolecular Biology, 1990, 15(2), 245-256. can be employed.

As a method that involves direct introduction of DNA containing arecombinant expression vector and a target gene, into plant cellsmicroinjection, electroporation, a polyethylene glycol method, aparticle gun method, protoplast fusion, a calcium phosphate method, orthe like can be employed.

Also, when a method that involves direct introduction of DNA into plantcells is employed, DNA to be used herein contains at leasttranscriptional units that are required for the expression of a targetgene such as a promoter and a transcriptional terminator, and the targetgene. Vector functions are not essential herein. Furthermore, even ifDNA contains only the protein coding region of a target gene having notranscriptional unit, such DNA can also be used herein, as long as itcan he integrated into a host transcriptional unit and the target genecan be expressed.

Examples of plant cells, into which DNA containing the above recombinantexpression vector and a target gene or DNA containing only target geneDNA without containing any expression vector is introduced, includecells of each tissue in plant organs such as flowers, leaves, and roots,calli, and suspension-cultured cells. In a method for producing theplant body according to the present invention, as the above recombinantexpression vector, an appropriate vector may be adequately constructeddepending on the type of a plant body to be produced. Alternatively, aversatile recombinant expression vector is constructed in advance andthen the vector may be introduced into plant cells. Specifically, themethod for producing the plant body according to the present inventionmay or may not comprise a step of constructing DNA for transformationusing the above recombinant expression vector.

Other Steps and Methods

A method for producing the plant body according to the present inventioncomprises at least the above transformation step. Furthermore, themethod may also comprise a step of constructing DNA for transformationusing the above recombinant expression vector and may further compriseother steps. Specifically, an example of such steps is a selection stepof selecting an appropriate transformant from transformed plant bodies.

A selection method is not particularly limited. For example, selectioncan be carried out based on drug resistance such as hygromycinresistance. Selection can also be carried out based on dry weights ofplant bodies themselves or dry weights of arbitrary organs or tissuesafter transformants are grown. For example, an example of a selectionmethod based on dry weights is a method that involves collecting theabove-ground parts of plant bodies, performing dry treatment underpredetermined conditions, measuring the weights, and then comparing theweights with the dry weights of the above-ground parts of untransformedplant bodies (see Examples described later).

In the method for producing the plant body according to the presentinvention, the above fusion gene is introduced into plant bodies, so asto make it possible to obtain, from the plant bodies, progeny withsignificantly improved fat and oil contents through sexual reproductionor asexual reproduction. Also, it becomes possible to obtain, from theplant bodies or the progeny thereof, plant cells and propagationmaterials such as seeds, fruits, stocks, call, tubers, cuttings, andmasses so as to mass-produce the plant bodies based on them. Therefore,the method for producing the plant body according to the presentinvention may comprise a propagation step (mass-production steppropagation of plant bodies after selection.

In addition, examples of the plant body of the present invention includeat least any one of grown individual plants, plant cells, plant tissues,calli, and seeds. Specifically, in the present invention, they are allregarded as plant bodies, as long as they are in a state such that theycan be finally grown to individual plants. Also, examples of the aboveplant cells include plant cells of various forms. Examples of such plantcells include suspension-cultured cells, protoplasts, and leaf sections.Plant bodies can be obtained by growing and causing differentiation ofthese plant cells. In addition, regeneration of plant bodies from plantcells can he carried out by a conventionally) known method depending onthe type of plant cell. Therefore, the method for producing the plantbody according to the present invention may comprise a regeneration stepfor regenerating plant bodies from plant cells or the like.

Also, the method for producing the plant body according to the presentinvention is not limited to a method that involves transformation usinga recombinant expression vector, and other methods may also be employed.Specifically, for example, the above chimeric protein (fusion protein)may be directly administered to plant bodies. In this case, a chimericprotein (fusion protein) is administered to plant bodies in their earlylife, so that fat and oil contents can be improved at sites of plantbodies that are finally used. Moreover, a method for administration of achimeric protein (fusion protein) is also not particularly limited, andvarious known methods may be employed for such purpose.

As explained above, according to the present invention, throughexpression of a chimeric protein of a predetermined transcriptionalfactor and the above functional peptide, plant bodies can be provided,wherein plant weights (that is, biomass levels) are improved andsubstance productivity per individual plant is changed (improved ordecreased) compared with that of wild-type plant bodies. When the abovechimeric protein is expressed by plant bodies, the activity foraccelerating transcription of a target transcriptional factor may besuppressed or transcriptional repression effects may be exerted on thehomologous sequence of a cis sequence that is recognized by the targettranscriptional factor. Furthermore, the chimeric protein may act toalter the affinity specificity of another factor, DNA, RNA, lipid, orcarbohydrate that has affinity for the target transcriptional factor ortranscription coupling factor. Alternatively, the chimeric protein mayact to improve the affinity of a substance that has no affinity for thetarget transcriptional factor. In the plant body according to thepresent invention, a target transcriptional factor of a chimericprotein, a transcriptional factor that recognizes a cis sequence havinghomology with a cis sequence to be recognized by the targettranscriptional factor, a transcriptional factor having homology withthe target transcriptional factor of the chimeric protein, other factorshaving affinity for the target transcriptional factor of the chimericprotein, and the like are similarly expressed. However, gene expressionto be controlled can be suppressed dominant-negatively because of theabove-described action and effects of the chimeric protein. Accordingly,it is thought that in the plant body according to the present invention,the expression level of a gene group involved in plant growth as well asthe expression level of a gene group involved in fat and oil productionand/or decomposition of the produced fats and oils are changed, as aresult, the biomass levels are significantly improved and fat and oilcontents are significantly changed.

Here, the expression, “fat and oil contents are significantly changed”refers to a case in which fat and oil levels are improved although theseed mass per grain remains unchanged compared with that of wild-typeplants; a case in which fat and oil levels are improved while the seedmass per grain is significantly increased or decreased compared withthat of wild-type plants; or a case in which fat and oil contents inseeds are improved or decreased compared with those of wild-type plants.In any case, the level of fats and oils produced by an individual plantis changed.

More specifically, when a chimeric protein of the transcriptional factorAt3g04070 or the transcriptional factor At1g18330 is expressed, thebiomass level in the plant body is increased, but the fat and oilcontent is decreased. In contrast, when a chimeric protein of thetranscriptional factor At3g45150 is expressed, both the biomass leveland the fat and oil content are increased.

Among examples of the plant body according to the present invention,plant bodies in which fat and oil contents are increased can be used fora method for producing plant-derived fats and oils. For example, fatsand oils can be produced by growing the plant body according to thepresent invention, harvesting seeds, and then collecting fat and oilcomponents from the harvested seeds. Particularly, a method forproducing fats and oils using the plant body according to the presentinvention can be said to be excellent in productivity because the fatand oil content of the thus produced individual plant is high. That isto say, if it is assumed that the number of cultivated plants per unitof cultivated area stays constant, the fat and oil level produced perunit of cultivated area can be significantly improved through the use ofthe plant body according to the present invention. Therefore, the use ofthe plant body according to the present invention makes it possible tosignificantly reduce the production costs of fats and oils.

Furthermore, a method for producing fats and oils using the plant bodyaccording to the present invention can be said to be excellent inproductivity because of resulting high fat and oil contents in seeds perunit of weight.

In addition, examples of fats and oils to be produced by the method forproducing fats and oils using the plant body according to the presentinvention are not particularly limited and include plant-derived fatsand oils such as soybean oil, sesame oil, olive oil, coconut oil, riceoil, cottonseed oil, sunflower oil, corn oil, safflower oil, andrapeseed oil. Moreover, the thus produced fats and oils can be broadlyused for household and industrial applications. The fats and oils canfurther be used as raw materials for biodiesel fuel. Specifically,through the use of plant bodies according to the present invention, theabove-mentioned fats and oils for household or industrial applications,biodiesel fuel, or the like can be produced at low cost.

In addition, among examples of the plant body according to the presentinvention, plant bodies with decreased fat and oil contents can be usedfor a method for producing bioalcohol using lignocellulose contained inplants. Specifically, bioalcohol with excellent glycosylation efficiencyand low impurity content can be produced due to the low levels of tatand oil components (which are impurities) in the step of glycosylatinglignocellulose.

EXAMPLES

The present invention will be described in detail using examples asfollows, but the technical scope of the present invention is not limitedby these examples.

Example 1

Amplification of Transcriptional Factor Gene

A DNA fragment of the coding region of transcriptional factor At3g04070excluding the termination codon was amplified by PCR using primersdescribed below from an Arabidopsis thaliana cDNA library. PCR wasperformed in 25 cycles each consisting of 94 degrees C. for 1 minute, 47degrees C. for 2 minutes and an extension reaction at 74 degrees C. for1 minute. Next, PCR products were separated and collected by agarose gelelectrophoresis.

Forward primer 1 (SEQ ID NO: 7) GATGATAAGCAAGGATCCAAGATCGAGTTT Reverse primer 1 (SEQ ID NO: 8) GCCTTGATATTGAAGGTGAGAACTCATCAT 

Preparation of Modified Transcriptional Factor

A p35SSXG vector having an Sma I site and a repressor domain (amino acidsequence: GLDLDLELRLGFA (SEQ ID NO: 9)) sequence downstream of a CaMV35Spromoter was used to add a repressor domain sequence to the 3′ end ofthe transcriptional factor gene encoded by the DNA fragment. To link thetranscriptional factor gene sequence and the repressor domain sequence,the vector was digested with Sma I and then the PCR amplified fragmentencoding the above transcriptional factor was inserted. Thus, p35SSXG(At3g04070) was prepared.

Construction of Modified Transcriptional Factor Expression Vector

For gene transfer into plants using Agrobacterium, pBCKH was used as abinary vector. This vector was constructed by incorporating a Gatewayvector conversion system cassette (Invitrogen) into the Hind III site ofpBIG (Hygr) (Nucleic Acids Res. 18, 203 (1990)). To incorporate themodified transcriptional factor gene sequence into the vector, thevector and p35SSXG (At3g04070) were mixed and then a recombinationreaction was carried out using GATEWAY LR clonase (Invitrogen). Thus,pBCKH-p35SSXG (At3g04070) was constructed.

Introduction of Modified Transcriptional Factor Gene Expression VectorInto Plant

Arabidopsis thaliana (Columbia (Col-0)) was used as a plant forintroduction of the modified transcriptional factor. Gene transfer wascarried out according to Transformation of Arabidopsis thaliana byVacuum Infiltration (http://www.bch.msu.edu/pamgreen/protocol.htm).However, plants were only infected by immersing them in an Agrobacteriumsolution without performing decompression treatment. Specifically, themodified transcriptional factor expression vector pBCKH-p35SSXG(At3g04070) was introduced into soil bacterium Agrobacterium tumefaciensstrain GV3101 (C58C1Rifr) pMP90 (Gmr) (konez and Schell 1986) strain byelectroporation. The thus introduced bacteria were cultured in 1 literof YEP medium containing an antibiotic (kanamycin (Km): 50 microgram/ml;gentamicin (Gm): 25 microgram/ml rifampicin (Rif): 50 microgram/ml)until OD600 reached 1. Subsequently, bacteria were collected from theculture solution and then suspended in 1 liter of medium for infection(infiltration medium containing 2.2 g of MS salt, 1× B5 vitamins, 50 gof sucrose, 0.5 g of MES, 0.044 micro M benzylaminopurine, and 400microliter of Silwet per liter; pH 5.7).

Arabidopsis thaliana plants grown for 14 days were immersed in thesolution for 1 minute for infection. After infection, cultivation wascontinued to fructification. Harvested seeds (T1 seeds) were sterilizedin 50% bleach with 0.02% Triton X-100 solution for 7 minutes, rinsed 3times with sterile water, and then germinated on a sterilized hygromycinselective medium (4.3 g/l MS salts, 0.5% sucrose, 0.5 g/l MES, pH 5.7,0.8% agar, 30 mg/l hygromycin, and 250 mg/l Vancomycin). Ten (10) linesof transformed plant bodies (T1 plants) that had grown on the abovehygromycin selective medium were selected per modified transcriptiongene. Plants were then transplanted into pots with a diameter of 50 mmcontaining vermiculite mixed with soil. They were cultivated at 22degrees C. under 16-hour-light/8-hour-dark photoperiods and lightintensity ranging from approximately 60 to 80 micro mol m⁻²s⁻¹. Thus,seeds (T2 seeds) were obtained.

Analysis of T2 Seed

Ten (10) lines into which At3g04070-SRDX had been introduced were eachanalyzed. Fat and oil contents were measured for T1 generation plantsand T2 seeds.

Quantitative analysis of fats and oils was conducted using MARAN-23(Resonance Instruments Ltd., UK) H-NMR and analysis software RI-NMR Ver.2.0, so that 2 mg to 10 mg of Arabidopsis thaliana seeds were measured.A calibration curve was produced using olive oil as a standard substancefor fats and oils. Thus, fat and oil contents (% by weight) in seedswere found.

The results of analyzing T2 seeds of the 10 lines produced for theAt3g04070-SRDX gene are summarized in Table 1. The seed fat and oilcontent of control WT into which no gene had been introduced was34.9+/−3.8%. The fat and oil contents of lines into which the modifiedtranscriptional factor gene had been introduced were 19.5% at minimumand 29.4% at maximum.

TABLE 1 Line name Fat and oil content At3g04070SRDX-1 19.5%At3g04070SRDX-2 19.9% At3g04070SRDX-3 23.3% At3g04070SRDX-4 27.4%At3g04070SRDX-5 26.8% At3g04070SRDX-6 28.0% At3g04070SRDX-7 28.6%At3g04070SRDX-8 29.4% At3g04070SRDX-9 25.5% At3g04070SRDX-10 24.1% WT(n= 34) 34.9 ± 3.8%

Analysis of Biomass

T2 seeds of 2 lines out of 10 lines into which the At3 04070-SRDX genehad been introduced were germinated and then cultivated. The biomasslevel per individual plant was measured.

First, T2 plants were cultivated for analysis of T3 plant bodies. T2seeds were sterilized in 50% bleach with 0.02% Triton X-100 solution for7 minutes, rinsed 3 times with sterile water, and then germinated onsterilized medium for germination (4.3 g/l MS salts, 0.5% sucrose, pH5.7, 0.8% agar, and 10 mg/l hygromycin). Three (3) weeks aftergermination, the thus grown individual plants into which the gene hadbeen introduced (specifically, 5 to 6 transformed plant bodies (T2plants) per line) were transplanted into pots with a diameter of 50 mmcontaining vermiculite mixed with soil. As control plants, fournon-recombinant Arabidopsis thaliana plants were transplanted. They werefurther cultivated at 22 degrees C. under 16-hour-light/8-hour-darkphotoperiods and light intensity ranging from approximately 30 to 45micro mol m⁻²s⁻¹ for 11 weeks.

Above-the-ground plant bodies were put into paper bags and then driedunder conditions of 22 degrees C. and humidity of 60% for 2 weeks. Totalbiomass weight levels were then determined. The results are shown inTable 2.

TABLE 2 Biomass weight Percentage Biomass weight increase in Sample name(mg) biomass At3g04070SRDX-1-1 915.5 4.0% At3g04070SRDX-1-2 978.6 11.1%At3g04070SRDX-1-3 936.2 6.3% At3g04070SRDX-1-4 1048.0 19.0%At3g04070SRDX-1-5 910.0 3.3% At3g04070SRDX-1-6 946.9 7.5% average 955.98.6% At3g04070SRDX-2-1 1019.7 15.8% At3g04070SRDX-2-2 1037.2 17.8%At3g04070SRDX-2-3 1016.6 15.4% At3g04070SRDX-2-4 987.7 12.2%At3g04070SRDX-2-5 1027.2 16.6% average 1017.7 15.6% WT1 903.4 — WT2880.3 — WT3 911.1 — WT4 827.6 — average 880.6 —

As a result, the biomass level per individual plant of the line intowhich the At3g04070-SRDX gene had been introduced was increased by 19%at maximum compared with that of the wild-type plants. Also, the biomasslevels of the two lines were increased by 8.6% and 15.6%, respectively,on average. Hence, the biomass production per individual plant could beincreased through introduction of the above modified transcriptionalfactor gene At3g04070-SRDX into which the repressor domain had beenadded. In addition, regarding At3g04070, functions relating to biomasshave never before been reported.

Example 2

Amplification of Transcriptional Factor Gene

A DNA fragment of the coding region of transcriptional factor At1g18330excluding the termination codon was amplified by PCR using primersdescribed below from Arabidopsis thaliana cDNA library. PCR wasperformed in 25 cycles each consisting of 94 degrees C. for 1 minute, 47degrees C. for 2 minutes, and an extension reaction at 74 degrees C. for1 minute. Next, PCR products were separated and collected by agarose gelelectrophoresis.

Forward primer 1 (SEQ ID NO: 10) GATGGCCGCTGAGGATCGAAGTGAGGAACT Reverse primer 1 (SEQ ID NO: 11) GCATATACGTGCTCTTTGGCTTTTCTTTTC

Preparation of Modified Transcriptional Factor

A p35SSXG vector having Sma I site and a repressor domain (amino acidsequence: GLDLDLELRLGFA (SEQ ID NO: 9)) sequence downstream of a CaMV35Spromoter was used to add a repressor domain sequence to the 3′ end ofthe transcriptional factor gene encoded by the DNA fragment. To link thetranscriptional factor gene sequence and the repressor domain sequence,the vector was digested with Sma I and then the PCR amplified fragmentencoding the above transcriptional factor was inserted. Thus, p35SSXG(At1g18330) was prepared.

Construction of Modified Transcriptional Factor Expression Vector

For gene transfer using Agrobacterium into plants, pBCKH was used as abinary vector. This vector was constructed by incorporating a cassetteof a Gateway vector conversion system (Invitrogen) into Hind III site ofpBIG (Hygr) (Nucleic Acids Res. 18, 203 (1990)). To incorporate themodified transcriptional factor gene sequence into the vector, thevector and p35SSXG (At1g18330) were mixed and then a recombinationreaction was carried out using GATEWAY LR clonase (Invitrogen). Thus,pBCKH-p35SSXG (At1g18330) was constructed.

Introduction of Modified Transcriptional Factor Gene Expression VectorInto Plant

Arabidopsis thaliana (Columbia (Col-0)) was used as a plant forintroduction of the modified transcriptional factor. Gene transfer wascarried out according to Transformation of Arabidopsis thaliana byVacuum Infiltration (http://www.bch.msu.edu/pamgreen/protocol.htm).However, plants were only infected by immersing them in an Agrobacteriumsolution without performing decompression treatment. Specifically, themodified transcriptional factor expression vector pBCKH-p35SSXG(At1g18330) was introduced into soil bacterium Agrobacterium tumefaciensstrain GV3101 (C58C1Rifr) pMP90 (Gmr) (konez and Schell 1986) strain byelectroporation. The thus introduced bacteria were cultured in 1 literof YEP medium containing an antibiotic (kanamycin (Km) 50 microgram/ml,gentamicin (Gm) 25 microgram/ml, and rifampicin (Rif) 50 microgram/ml)until OD600 reached 1. Subsequently, bacteria were collected from theculture solution and then suspended in 1 liter of medium for infection(Infiltration medium containing 2.2 g of MS salt, 1× B5 vitamins, 50 gof sucrose, 0.5 g of MES, 0.044 micro M benzylaminopurine, and 400microliter of Silwet per liter; pH5.7).

Arabidopsis thaliana plants grown for 14 days were immersed in thesolution for 1 minute for infection. After infection, cultivation wascontinued to fructification. Harvested seeds (T1 seeds) were sterilizedin 50% bleach with 0.02% Triton X-100 solution for 7 minutes, rinsed 3times with sterile water, and then germinated on sterilized hygromycinselective medium (4.3 g/l MS salts, 0.5% sucrose, 0.5 g/l MES, PH 5.7,0.8% agar, 30 mg/l hygromycin, and 250 mg/l Vancomycin). Ten (10) linesof transformed plant bodies (T1 plants) that had grown on the abovehygromycin selective medium were selected per modified transcriptiongene. Plants were then transplanted into pots with a diameter of 50 mmcontaining vermiculite mixed with soil. They were cultivated at 22degrees C. under 16-hour-light/8-hour-dark photoperiods and lightintensity ranging from approximately 60 to 80 micro mol m⁻²s⁻¹. Thus,seeds (T2 seeds) were obtained.

Analysis of T2 Seed

Ten (10) lines into which At1g18330-SRDX had been introduced were eachanalyzed. Fat and oil contents were measured for T1 generation plantsand T2 seeds. Quantitative analysis of fats and oils was conducted usingMARAN-23 (Resonance Instruments Ltd., UK) H-NMR and analysis softwareRI-NMR Ver. 2.0, so that 2 mg to 10 mg of Arabidopsis thaliana seedswere measured. A calibration curve was produced using olive oil as astandard substance for fats and oils. Thus, fat and oil contents (% byweight) in seeds were found.

The results of analyzing T2 seeds of the 10 lines produced for theAt1g18330-SRDX gene are summarized in Table 3. The seed fat and oilcontent of control WT into which no gene had been introduced was34.9+/−3.8%. The fat and oil contents of lines into which the modifiedtranscriptional factor gene had been introduced were 22.0% at minimumand 33.7% at maximum.

TABLE 3 Percentage Gene name Lipid level decrease At1g18330-1 33.7%−3.6% At1g18330-2 30.2% −13.5% At1g18330-3 30.6% −12.3% At1g18330-424.7% −29.3% At1g18330-5 26.2% −24.9% At1g18330-6 26.5% −24.2%At1g18330-7 22.8% −34.6% At1g18330-8 22.0% −37.0% At1g18330-9 26.9%−23.0% At1g18330-10 32.8% −5.9% WT(n = 34) 34.9 ± 3.8%

Analysis of Biomass

T2 seeds of 1 line out of the 10 lines into which the At1g18330-SRDXgene had been introduced were germinated and then cultivated. Thebiomass level per individual plant was measured. First, T2 plants werecultivated for analysis of T3 plant bodies. T2 seeds were sterilized in50% bleach with 0.02% Triton X-100 solution for 7 minutes, rinsed 3times with sterile water, and then germinated on sterilized medium forgermination (4.3 g/l MS salts, 0.5% sucrose, pH 5.7, 0.8% agar, and 10mg/l hygromycin). Three (3) weeks after germination, the thus grownindividual plants into which the gene had been introduced (specifically,4 transformed plant bodies (T2 plants)) were transplanted into pots witha diameter of 50 mm containing vermiculite mixed with soil. As controlplants, four non-recombinant Arabidopsis thaliana plants weretransplanted. They were further cultivated at 22 degrees C. under16-hour-light/8-hour-dark photoperiods and light intensity ranging fromapproximately 30 to 45 micro mol m⁻²s⁻¹ for 11 weeks.

Above-the-ground plant bodies were put into paper bags and then driedunder conditions of 22 degrees C. and humidity of 60% for 2 weeks. Totalbiomass weight levels were then determined. The results are shown inTable 4.

TABLE 4 Percentage Biomass weight increase in Sample name (mg) biomassAt1g18330SRDX-5-1 978.8 13.9% At1g18330SRDX-5-2 1202.5 39.9%At1g18330SRDX-5-3 1015.9 18.2% At1g18330SRDX-5-4 884.8 3.0% average1020.5 18.8% WT1 698.0 — WT2 958.6 — WT3 884.1 — WT4 896.2 — average859.2 —As a result, the biomass level per individual plant of the line intowhich the At1g18330-SRDX gene had been introduced was increased by 39.9%at maximum compared with that of the wild-type plants. Also, the biomasslevel per individual plant of each line was increased by 18.8%, onaverage. Hence, the biomass production per individual plant could beincreased through introduction of the above modified transcriptionalfactor gene At1g18330-SRDX into which the repressor domain had beenadded. In addition, regarding At1g18330, there is a report thatflowering is delayed by functional deficiency, but there is no reportthat it relates to biomass.

Example 3

Amplification of Transcriptional Factor Gene

A DNA fragment of the coding region of transcriptional factor At3g45150excluding the termination codon was amplified by PCR using primersdescribed below from Arabidopsis thaliana cDNA library. PCR wasperformed in 25 cycles each consisting of 94 degrees C. for 1 minute, 47degrees C. for 2 minutes, and an extension reaction at 74 degrees C. for1 minute. Next, PCR products were separated and collected by agarose gelelectrophoresis.

Forward primer 1 (SEQ ID NO: 12) ATGGATTCGAAAAATGGAATTAAC Reverse primer 1 (SEQ ID NO: 13) AACTGTGGTTGTGGCTGTTGTTG 

Preparation of Modified Transcriptional Factor

A p35SSXG vector having an Sma I site and a repressor domain (amino acidsequence: GLDLDLELRLGFA (SEQ ID NO: 9)) sequence downstream of a CaMV35Spromoter was used to add a repressor domain sequence to the 3′ end ofthe transcriptional factor gene encoded by the DNA fragment. To link thetranscriptional factor gene sequence and the repressor domain sequence,the vector was digested with Sma I and then the PCR amplified fragmentencoding the above transcriptional factor was inserted. Thus, p35SSXG(At3g45150) was prepared.

Construction of Modified Transcriptional Factor Expression Vector

For gene transfer using Agrobacterium into plants, pBCKH was used as abinary vector. This vector was constructed by incorporating a cassetteof a Gateway vector conversion system (Invitrogen) into a Hind III siteof pBIG (Hygr) (Nucleic Acids Res. 18, 203 (1990)). To incorporate themodified transcriptional factor gene sequence into the vector, thevector and p35SSXG (At3g45150) were mixed and then a recombinationreaction was carried out using GATEWAY LR clonase (Invitrogen). Thus,pBCKH-p35SSXG (At3g45150) was constructed.

Introduction of Modified Transcriptional Factor Gene Expression VectorInto Implant

Arabidopsis thaliana (Columbia (Col -0)) was used as a plant forintroduction of the modified transcriptional factor. Gene transfer wascarried out according to Transformation of Arabidopsis thaliana byVacuum Infiltration (http://www.bch.msu.edu/pamgreen/protocol.htm).However, plants were only infected by immersing them in an Agrobacteriumsolution without performing decompression treatment. Specifically, themodified transcriptional factor expression vector pBCKH-p35SSXG(At3g45150) was introduced into soil bacterium Agrobacterium tumefaciensstrain GV3101 (C58C1Rifr) pMP90 (Gmr) (konez and Schell 1986) strain byelectroporation. The thus introduced bacteria were cultured in 1 literof YEP medium containing an antibiotic (kanamycin (Km) 50 microgram/ml,gentamicin (Gm) 25 microgram/ml, and rifampicin (Rif) 50 microgram/ml)until OD600 reached 1. Subsequently, bacteria were collected from theculture solution and then suspended in 1 liter of medium for infection(Infiltration medium containing 2.2 g of MS salt, 1× B5 vitamins, 50 gof sucrose, 0.5 g of MES, 0.044 micro M benzylaminopurine, and 400microliter of Silwet per liter; pH5.7).

Arabidopsis thaliana plants grown for 14 days were immersed in thesolution for 1 minute for infection. After infection, cultivation wascontinued to fructification. Harvested seeds (T1 seeds) were sterilizedin 50% bleach with 0.02% Triton X-100 solution for 7 minutes, rinsed 3times with sterile water, and then germinated on sterilized hygromycinselective medium (4.3 g/l MS salts, 0.5% sucrose, 0.5 g/l MES, pH 5.7,0.8% agar, 30 mg/l hygromycin, and 250 mg/l Vancomycin). Ten (10) linesof transformed plant bodies (T1 plants) that had grown on the abovehygromycin selective medium were selected per modified transcriptiongene. Plants were then transplanted into pots with a diameter of 50 mmcontaining vermiculite mixed with soil. They were cultivated at 22degrees C. under 16-hour-light/8-hour-dark photoperiods and lightintensity ranging from approximately 60 to 80 micro mol m⁻²s⁻¹. Thus,seeds (T2 seeds) were obtained.

Analysis of Fat and Oil Content in T2 Seed

Ten (10) lines into which At3g45150-SRDX had been introduced were eachanalyzed. Fat and oil contents were measured for T1 generation plantsand T2 seeds. Quantitative analysis of fats and oils was conducted usingMARAN-23 (Resonance Instruments Ltd., UK) H-NMR and analysis softwareRI-NMR. Ver. 2.0, so that 2 mg to 10 mg of Arabidopsis thaliana seedswere measured. A calibration curve was produced using olive oil as astandard substance for fats and oils. Thus, fat and oil contents (% byweight) in seeds were found.

As a result of analyzing T2 seeds of the 10 lines produced for theAt3g45150-SRDX gene, the fat and oil contents in T2 seeds of the 10lines were 46.4%, 40.7%, 40.0%, 35.7%, 35.4%, 34.8%, 33.6%, 31.1%,30.6%, and 26.7% (46.4% at maximum and 26.7% at minimum). The seed fatand oil content of control WT into which no gene had been introduced was34.9+/−3.8%. From these lines, the line with the fat and oil content of40.7% was used for the subsequent experiments.

Cultivation Test and Analysis of Biomass and Fat and Oil Content

T2 seeds of 1 line out of the 10 lines into which the At305150-SRDX genehad been introduced were germinated and then cultivated. The biomasslevel per individual plant was measured. First, T2 plants werecultivated for analysis of T3 plant bodies. T2 seeds were sterilized in50% bleach with 0.02% Triton X-100 solution for 7 minutes, rinsed 3times with sterile water, and then germinated on sterilized medium forgermination (4.3 MS salts, 0.5% sucrose, pH 5.7, 0.8% agar, and 10 mg/lhygromycin). Three (3) weeks after germination, the thus grownindividual plants into which the gene had been introduced (specifically,5 transformed plant bodies (T2 plants)) were transplanted into pots witha diameter of 50 mm containing vermiculite mixed with soil. As controlplants, four non-recombinant Arabidopsis thaliana plants weretransplanted. They were further cultivated at 22 degrees C. under16-hour-light/8-hour-dark photoperiods and light intensity ranging fromapproximately 30 to 45 micro mol m⁻²s⁻¹ for 11 weeks.

Above-the-ground plant bodies were put into paper bags and then driedunder conditions of 22 degrees C. and humidity of 60% for 2 weeks. Totalbiomass weight levels were then determined and the above fat and oilcontents were measured. The results are shown in Table 5.

TABLE 5 Percentage Biomass Percentage Fat and oil increase weightincrease in content in in fats Sample name (mg) biomass seed and oilsAt3g45150SRDX-27-1 893.7 25.9% 36.0% 3.1% At3g45150SRDX-27-2 875.3 23.3%36.6% 4.9% At3g45150SRDX-27-3 1115.7 57.2% 37.1% 6.5% At3g45150SRDX-27-5820.1 15.6% 35.1% 0.7% At3g45150SRDX-27-6 827.7 16.6% 35.9% 3.0% average906.5 27.7% 36.1% 3.7% WT1 818.7 — 35.3% — WT2 784.5 — 34.8% — WT3 627.5— 35.2% — WT4 608.0 — 34.1% — average 709.6 — 34.9% —As a result, the biomass level per individual plant of the line intowhich the At3g45150-SRDX gene had been introduced was increased by 57.2%at maximum compared with that of the wild-type plants. The biomass levelper individual plant of each line was increased by 27.7% on average.Also, when the fat and oil contents in dry seeds were measured by pulseNMR, they were confirmed to be improved by 6.5% at maximum and 3.7% onaverage. Hence, the biomass production per individual plant could beincreased through introduction of the above modified transcriptionalfactor gene At3g45150-SRDX into which the repressor domain had beenadded. In addition, regarding At3g45150, there is a report thatfunctional deficiency induces underdevelopment of pollens, but there isno report that this matter relates to biomass.

1-16. (canceled)
 17. A method for producing a plant exhibiting animproved biomass level and having an improved productivity of asubstance per individual plant compared with a wild type plant,comprising the steps of: introducing a fusion gene into a plant, whereinthe fusion gene codes for a chimeric protein comprising atranscriptional factor comprising any one of the following proteins (a)to (b) and a functional peptide that converts an arbitrarytranscriptional factor into a transcriptional repression factor: (a) aprotein comprising the amino acid sequence shown in SEQ ID NO: 2; and(b) a protein comprising the amino acid sequence of SEQ ID NO: 2 butwith 1-20 amino acid changes, wherein said amino acid changes areselected from the group consisting of a deletion, a substitution, anaddition, and an insertion, and wherein the protein has an activity ofaccelerating transcription, and selecting a plant having the introducedfusion gene, exhibiting an improved biomass level and having an improvedproductivity of a substance compared with a wild type plant.
 18. Themethod according to claim 17, wherein the activity of acceleratingtranscription of the transcriptional factor is suppressed.
 19. Themethod according to claim 17, wherein the chimeric protein hastranscriptional repression factor activity.
 20. The method according toclaim 17, wherein the functional peptide has the amino acid sequencerepresented by any one of the following formulae (1) to (8): (1) X1-Leu-Asp-Leu-X2-Leu-X3 (SEQ ID NO: 14 with deletion of 0-10 residuesfrom the N-terminus) (wherein X1 denotes 0 to 10 amino acid residues, X2denotes Asn or Glu, and X3 denotes at least 6 amino acid residues); (2)Y1-Phe-Asp-Leu-Asn-Y2-Y3 (SEQ ID NO: 15 with deletion of 0-10 residuesfrom the N-terminus) (wherein Y1 denotes 0 to 10 amino acid residues, Y2denotes Phe or Ile, and Y3 denotes at least 6 amino acid residues); (3)Z1-Asp-Leu-Z2-Leu-Arg-Leu-Z3 (SEQ ID NO: 16 with deletion of 0-10residues from the C-terminus and deletion of 0-2 residues from theN-terminus) (wherein Z1 denotes Leu, Asp-Leu, or Leu-Asp-Leu, Z2 denotesGlu, Gln, or Asp, and Z3 denotes 0 to 10 amino acid residues); (4)Asp-Leu-Z4-Leu-Arg-Leu (SEQ ID NO: 17) (wherein Z4 denotes Glu, Gln, orAsp); (5) α1-Leu-γ1-Leu-yl-Leu (SEQ ID NO: 18); (6) α1-Leu-β1-Leu-γ2-Leu(SEQ ID NO: 19); (7) α1-Leu-β1-Leu-Arg-Leu (SEQ ID NO: 20); and (8)α2-Leu-β1-Leu-Arg-Leu (SEQ ID NO: 21) (and in the formulae (5) to (8),α1 denotes Asp, Asn, Glu, Gln, Thr, or Ser, α2 denotes Asn, Glu, Gln,Thr, or Ser, β1 denotes Asp, Gln, Asn, Arg, Glu, Thr, Ser, or His, β2denotes Asn, Arg, Thr, Ser, or His, γ1 denotes Arg, Gln, Asn, Thr, Ser,His, Lys, or Asp, and γ2 denotes Gln, Asn, Thr, Ser, His, Lys, or Asp).21. The method according to claim 17, wherein the plant weight issignificantly improved.
 22. The method according to claim 17, whereinthe substance productivity per individual plant is productivity of fatsand oils contained in seeds.
 23. The method according to claim 17,wherein the plant is an angiosperm.
 24. The method according to claim17, wherein the plant is a dicotyledon.
 25. The method according toclaim 17, wherein the plant is a plant of the family Brassicaceae. 26.The method according to claim 17, wherein the plant is Arabidopsisthaliana.